A SYSTEMATIC LITERATURE REVIEW (SLR) TO SUPPORT NETWORK META-ANALYSES (NMA) IN THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (LA/MUC) FOLLOWING PD-1/L1 INHIBITORS

被引：0
|
作者：
Shah, S. N. [1 ]
Wissinger, E. [2 ]
Ballew, N. [2 ]
Hepp, Z. [3 ]
机构：
[1] Astellas Pharma Inc, Northbrook, IL USA
[2] Xcenda LLC, Palm Harbor, FL USA
[3] Seattle Genet, Bothell, WA USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN40
引用
收藏
页码：S443 / S443
页数：1
相关论文
共 50 条
  • [11] EFFICACY AND SAFETY OF PD-1/PD-L1 INHIBITORS USED IN THE TREATMENT OF PATIENTS WITH ADVANCED AND METASTATIC MELANOMA - A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Oguzhan, G.
    Caliskan, Z.
    Kockaya, G.
    Kurnaz, M.
    Calli, C.
    Erturk, S. M.
    VALUE IN HEALTH, 2020, 23 : S50 - S50
  • [12] EFFICACY AND SAFETY OF PD-1/PD-L1 INHIBITORS USED IN THE TREATMENT OF PATIENTS WITH ADVANCED AND METASTATIC MELANOMA - A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Verma, J.
    Verma, D.
    Maria, A.
    VALUE IN HEALTH, 2020, 23 : S50 - S50
  • [13] Impact of concurrent angiotensin inhibitors on outcomes with PD1/L1 inhibitors for patients (pts) with metastatic urothelial carcinoma (mUC).
    Agarwal, Archana
    Pond, Gregory Russell
    Curran, Catherine
    Nassar, Amin
    Nuzzo, Pier Vitale
    Kumar, Vivek
    McGregor, Bradley Alexander
    Wei, Xiao X.
    Harshman, Lauren Christine
    Choueiri, Toni K.
    Kilbridge, Kerry L.
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [14] Efficacy of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: A systematic review and meta-analysis
    Peng, Tzu-Rong
    Yang, Li-Jou
    Wu, Ta-Wei
    TZU CHI MEDICAL JOURNAL, 2024, 36 (03): : 340 - 348
  • [15] Clinical efficacy of lenvatinib, trans-arterial chemoembolization, and PD-1/L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and network meta-analysis
    Liang, Yifeng
    Gan, Liming
    Zeng, Dejin
    Lin, Langhua
    Xiong, Zhekun
    Liao, Fanglian
    Wang, Aling
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (10) : 2652 - 2664
  • [16] Patient and caregiver preferences for the treatment of locally advanced or metastatic urothelial carcinoma (la/mUC): Results of a targeted literature review (TLR).
    Kearney, Mairead
    Janssens, Rosanne
    Quaife, Matt
    Trapali, Myrto
    Thomas, Caitlin
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [17] Clinical benefits of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and meta-analysis
    Quan Rao
    Min Li
    Wei Xu
    Kai Pang
    XiaoBo Guo
    Dong Wang
    Jun Liu
    Wei Guo
    ZhongTao Zhang
    Hepatology International, 2020, 14 : 765 - 775
  • [18] Efficacy and Safety of PD-1/PD-L1 Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
    Yuwei Liu
    Jiahui Pan
    Fangbo Gao
    Wentao Xu
    Hongyu Li
    Xingshun Qi
    Advances in Therapy, 2023, 40 : 521 - 549
  • [19] Efficacy and Safety of PD-1/PD-L1 Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
    Liu, Yuwei
    Pan, Jiahui
    Gao, Fangbo
    Xu, Wentao
    Li, Hongyu
    Qi, Xingshun
    ADVANCES IN THERAPY, 2023, 40 (02) : 521 - 549
  • [20] Clinical benefits of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and meta-analysis
    Rao, Quan
    Li, Min
    Xu, Wei
    Pang, Kai
    Guo, XiaoBo
    Wang, Dong
    Liu, Jun
    Guo, Wei
    Zhang, ZhongTao
    HEPATOLOGY INTERNATIONAL, 2020, 14 (05) : 765 - 775
12345